Ueda et al. (2015) demonstrated a high degree of 68Ga-Df-anti-HER2 scFv accumulation in mice bearing HER2-positive tumor xenografts such that changes in HER2 status over the course of anti-HER2 treatment could be monitored in a noninvasive fashion. The gene discussed is ERBB2; the disease is neoplasm.